Where is VetStem located?

VetStem is headquartered in Poway, United States.

How many employees does VetStem have?

As of Aug 31, 2026, the latest employee count at VetStem is 27.

Where does VetStem rank among its competitors?

VetStem ranks 3rd amongst 21 active competitors, of which 9 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Gallant, which secured $18M in Jun, 2025.

Who are the top competitors of VetStem?

VetStem's top competitors include Gallant, Bioceltix and eQcell. Among them, Gallant secured the most recent funding round in June, 2025.

VetStem - 2026 Company Profile, Team & Competitors

VetStem is an unfunded company based in Poway (United States), founded in 2002 by Bob Harman. It operates as a Developer of vet stem cell therapy for animal health. VetStem has not raised any funding yet. The company has 21 active competitors, including 9 that are funded. Its top competitors include companies like Gallant, Bioceltix and eQcell.

Company Details

VetStem is a developer of vet stem cell therapy for animal health. It provides solutions for veterinarians and owners with a way to treat dogs, horses, and cats with the animal's own stem cells from a small sample of fat for arthritis and tendon and ligament injuries. Stem cells can also be stored as insurance for the future. It has developed steminsure that can be performed before the dog has arthritis or an injury so that when the dog needs stem cells, no additional fat collection surgery is required.

Website: vetstem.com
Social
Email ID: *****@vetstem.com
Phone Number: +1 **********

Key Metrics

Founded Year

2002

Location

Poway, United States

Stage

Unfunded

Ranked

3^rd among 21 active competitors

Employee Count

27 as on Aug 31, 2026

Similar Companies

Gallant & 23 more

View VetStem's full profile

VetStem has not raised any funding rounds yet.

The founders of VetStem is Bob Harman.

Here are the details of VetStem's key team members:

Bob Harman: Co-Founder & CEO of VetStem.

View details of VetStem's Founder profiles and Board Members

VetStem's employee count trend

VetStem has 27 employees as of Aug 26. Here is VetStem's employee count trend over the years:

Uncover VetStem's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VetStem include Gallant, Bioceltix and eQcell. Here is the list of Top 10 competitors of VetStem, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gallant 2018, Los Angeles (United States), Series B	Provider of stem cell based regenerative therapy for dogs	$61.5M	Bold Capital Partners, Digitalis Ventures ... & 13 others	55/100
2nd	Bioceltix 2017, Wroclaw (Poland), Seed	Developer of drugs for veterinary therapy	-	Infini, Leonarto	48/100
3rd	VetStem 2002, Poway (United States), Unfunded	Developer of vet stem cell therapy for animal health	-	-	43/100
4th	eQcell 2010, Guelph (Canada), Series A	Developer of stem cell therapies for the treatment of animals	$4.6M	Accelerator Centre, Ag Capital Canada	37/100
5th	Vetbiobank 2011, Marcy l Étoile (France), Seed	Veterinary regenerative medicine	$450K	Angelor, Health Angels Rhone-Alpes & 4 others	36/100
6th	Animal Cell Therapies 2008, San Diego (United States), Series A	Research and development of veterinary stem cell	$10.1M	Sabes Foundation	32/100
7th	RevaTis 2013, Luxemburg (United States), Funding Raised	Provider of undifferentiated muscle-derived stem	-	Noshaq, WBC Ventures	31/100
8th	Vetherapy 2015, San Francisco (United States), Seed	Provider of stem cell therapies for pets	$250K	IndieBio, EIC Fund & 1 others	30/100
9th	Global Stem cell Technology 2012, Evergem (Belgium), Acqui-Hired	Developer of blood-derived mesenchymal stem cells for clinical use in animals	-	-	29/100
10th	J-ARM 2006, Osaka (Japan), Seed	Developer of lymphocyte therapy and stem cell therapy for dogs and cats	-	Japan Asia Investment, Mitsubishi UFJ Capital ... & 2 others	29/100